Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)
China · Delayed Price · Currency is CNY 16.83
-0.24 (-1.41%)
Sep 17, 2025, 2:45 PM CST
SHE:002603 Revenue
Shijiazhuang Yiling Pharmaceutical had revenue of 1.68B CNY in the quarter ending June 30, 2025, a decrease of -19.21%. This brings the company's revenue in the last twelve months to 5.95B, down -26.85% year-over-year. In the year 2024, Shijiazhuang Yiling Pharmaceutical had annual revenue of 6.51B, down -36.88%.
Revenue (ttm)
5.95B
Revenue Growth
-26.85%
P/S Ratio
4.72
Revenue / Employee
508.06K
Employees
11,708
Market Cap
28.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.51B | -3.81B | -36.88% |
| Dec 31, 2023 | 10.32B | -2.21B | -17.67% |
| Jan 1, 2023 | 12.53B | 2.42B | 23.88% |
| Jan 1, 2022 | 10.12B | 1.33B | 15.19% |
| Dec 31, 2020 | 8.78B | 2.96B | 50.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Shanghai United Imaging Healthcare | 10.98B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |